Dendritic Cell-Cytokine-Induced Killer Cells Co-Loaded with WT1/MUC1/Poly(I:C) Enhance Antitumor Immune Responses In Vitro and In Vivo
Biomolecules · 2025
DOI: 10.3390/biom15101356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Huimin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Henan Agricultural University, Zhengzhou 450046, China. Hauptthemen laut MEDLINE: Poly I-C, Mucin-1, Dendritic Cells, Cytokine-Induced Killer Cells. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan Province, China Postdoctoral Science Foundation, Special Fund for Young Talents in Henan Agricultural University.
Abstract (Originalsprache)
Dendritic cell-cytokine-induced killer (DC-CIK) therapy faces limitations due to antigenic heterogeneity and suboptimal immune activation. In this study, we developed a multi-antigen-loaded DC-CIK (Ag-DC-CIK) system that co-targets Wilms’ tumor 1 (WT1), mucin-1 (MUC1), and the TLR3 agonist poly(I:C) to improve therapeutic outcomes. Utilizing umbilical cord blood-derived DC and CIK cells, we demonstrated that Ag-DC-CIK significantly enhanced cytotoxicity, as evidenced by the lactate dehydrogenase (LDH) assay, and increased apoptosis induction, indicated by elevated Bax and reduced Bcl-2 expression, in various tumor cell lines (HeLa, HCT116, MKN45) and organoids generated from a gastric cancer patient. Furthermore, Ag-DC-CIK effectively suppressed tumor cell migration and reduced the viability of the organoid. In MKN45 xenograft models, Ag-DC-CIK treatment inhibited tumor growth without inducing systemic toxicity, as shown by decreased Ki67 cell proliferation. This tripartite strategy synergistically enhances DC-CIK therapy by expanding antigen recognition and augmenting immune responses, presenting a promising translational approach for the treatment of gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Henan Agricultural University, Zhengzhou 450046, China.
- College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
- Biocomer Technology Co., Ltd., Xiamen 361011, China.
ORCID-Profile: Huimin Liu
Förderung
- Natural Science Foundation of Henan Province
- China Postdoctoral Science Foundation
- Special Fund for Young Talents in Henan Agricultural University
Zitieren
APA
Liu, H., Wang, C., Chang, H., Dong, L., Yang, G., Tong, C., & Mao, L. (2025). Dendritic Cell-Cytokine-Induced Killer Cells Co-Loaded with WT1/MUC1/Poly(I:C) Enhance Antitumor Immune Responses In Vitro and In Vivo. Biomolecules. https://doi.org/10.3390/biom15101356
Vancouver
Liu H, Wang C, Chang H, Dong L, Yang G, Tong C, et al. Dendritic Cell-Cytokine-Induced Killer Cells Co-Loaded with WT1/MUC1/Poly(I:C) Enhance Antitumor Immune Responses In Vitro and In Vivo. Biomolecules. 2025. doi:10.3390/biom15101356
BibTeX
@article{Liu2025,
author = {Liu, Huimin and Wang, Chenlong and Chang, Hongtao and Dong, Liangliang and Yang, Guoqing and Tong, Cailing and Mao, Lin},
title = {Dendritic Cell-Cytokine-Induced Killer Cells Co-Loaded with WT1/MUC1/Poly(I:C) Enhance Antitumor Immune Responses In Vitro and In Vivo},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15101356}
}
EUVIMED